Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug:192:113-115.
doi: 10.1016/j.thromres.2020.05.017. Epub 2020 May 15.

Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

F Galeano-Valle  1 , C M Oblitas  2 , M M Ferreiro-Mazón  2 , J Alonso-Muñoz  2 , J Del Toro-Cervera  1 , M di Natale  3 , P Demelo-Rodríguez  4
Affiliations
Comment

Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism

F Galeano-Valle et al. Thromb Res. 2020 Aug.

Abstract

  1. •

    COVID-19 pneumonia could be associated with an increased risk of venous thrombosis.

  2. •

    Antiphospholipid antibodies might be involved in thrombosis in COVID-19 patients.

  3. •

    Prevalence of antiphospholipid antibodies in COVID-19 and venous thrombosis was low.

PubMed Disclaimer

Comment in

Comment on

References

    1. Bruni-Fitzgerald K.R. Venous thromboembolism: an overview. J Vasc Nurs. 2015;33(3):95–99. - PubMed
    1. Lippi G., Plebani M., Michael Henry B. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145–148. - PMC - PubMed
    1. Lippi G., Favaloro E.J. (COVID-19): A Pooled Analysis. Thromb Haemost In press; 2019. D-dimer is associated with severity of coronavirus disease. - PMC - PubMed
    1. Tang N., Bai H., Chen X., Gong J., Li D., Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094–1099. - PMC - PubMed
    1. Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020 [epub ahead of print] - PMC - PubMed

Substances